相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Understanding the Molecular Determinants of Substrate and Inhibitor Specificities in the Carbapenemase KPC-2: Exploring the Roles of Arg220 and Glu276
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
MEROPENEM/CLAVULANATE AND LINEZOLID TREATMENT FOR EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
Nicolas Dauby et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Substrate Selectivity and a Novel Role in Inhibitor Discrimination by Residue 237 in the KPC-2 β-Lactamase
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Structures of the Michaelis Complex (1.2 Å) and the Covalent Acyl Intermediate (2.0 Å) of Cefamandole Bound in the Active Sites of the Mycobacterium tuberculosis β-Lactamase K73A and E166A Mutants
Lee V. Tremblay et al.
BIOCHEMISTRY (2010)
Biochemical and Structural Characterization of Mycobacterium tuberculosis β-Lactamase with the Carbapenems Ertapenem and Doripenem
Lee W. Tremblay et al.
BIOCHEMISTRY (2010)
Three Decades of beta-Lactamase Inhibitors
Sarah M. Drawz et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Mechanistic Basis for the Emergence of Catalytic Competence against Carbapenem Antibiotics by the GES Family of β-Lactamases
Hilary Frase et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Different Intermediate Populations Formed by Tazobactam, Sulbactam, and Clavulanate Reacting with SHV-1 β-Lactamases: Raman Crystallographic Evidence
Matthew Kalp et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Genome-wide regulon and crystal structure of BlaI (Rv1846c) from Mycobacterium tuberculosis
Claudia Sala et al.
MOLECULAR MICROBIOLOGY (2009)
PDBsum new things
Roman A. Laskowski
NUCLEIC ACIDS RESEARCH (2009)
Analysis of the plasticity of location of the Arg244 positive charge within the active site of the TEM-1 β-lactamase
David C. Marciano et al.
PROTEIN SCIENCE (2009)
Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
Jean-Emmanuel Hugonnet et al.
SCIENCE (2009)
Structure of the covalent adduct formed between Mycobacterium tuberculosis β-lactamase and clavulanate
Lee W. Tremblay et al.
BIOCHEMISTRY (2008)
GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation
Berk Hess et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)
Inhibition of class A β-lactamases by carbapenems:: Crystallographic observation of two conformations of meropenem in SHV-1
Michiyosi Nukaga et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Irreversible inhibition of the mycobacterium tuberculosis β-lactarnase by clavulanate
Jean-Emmanuel Hugonnet et al.
BIOCHEMISTRY (2007)
Crystal structure of KPC-2:: Insights into carbapenemase activity in class a β-lactamases
Wei Ke et al.
BIOCHEMISTRY (2007)
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
Neel R. Gandhi et al.
LANCET (2006)
Probing active site chemistry in SHV β-lactamase variants at ambler position 244 -: Understanding unique properties of inhibitor resistance
Jodi M. Thomson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Crystal structure and activity studies of the Mycobacterium tuberculosis β-lactamase reveal its critical role in resistance to β-lactam antibiotics
Feng Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Amino acid residues that contribute to substrate specificity of class A β-lactamase SME-1
FK Majiduddin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Structural consequences of the inhibitor-resistant Ser130Gly substitution in TEM-lactamase
VL Thomas et al.
BIOCHEMISTRY (2005)
Genetic analysis of the β-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to β-lactam antibiotics
AR Flores et al.
MICROBIOLOGY-SGM (2005)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Understanding resistance to β-lactams and β-lactamase inhibitors in the SHV β-lactamase -: Lessons from the mutagenesis of Ser-130
MS Helfand et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A graphical user interface to the CCP4 program suite
E Potterton et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2003)
Amino acid substitutions at ambler position Gly238 in the SHV-1 β-lactamase:: Exploring sequence requirements for resistance to penicillins and cephalosporins
AM Hujer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Inhibition of the SHV-1 β-lactamase by sulfones:: Crystallographic observation of two reaction intermediates with tazobactam
AP Kuzin et al.
BIOCHEMISTRY (2001)
GROMACS 3.0: a package for molecular simulation and trajectory analysis
E Lindahl et al.
JOURNAL OF MOLECULAR MODELING (2001)
分享论文
